More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake.

Sedona Sweeney ORCID logo; Maninder Pal Singh ORCID logo; (2022) More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake. The Lancet Global Health, 11 (2). e183-e184. DOI: 10.1016/S2214-109X(22)00519-8
Copy
Item Type Article
Elements ID 197529
Official URL http://dx.doi.org/10.1016/s2214-109x(22)00519-8

Explore Further

picture_as_pdf
Sweeny_Singh_2022_More-treatment-options-for-rifampicin-resistant.pdf
subject
Published Version
Available under Creative Commons: 4.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads